STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $26.19 billion. The enterprise value is $27.93 billion.
| Market Cap | 26.19B |
| Enterprise Value | 27.93B |
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Nov 18, 2025 |
Share Statistics
STERIS has 98.15 million shares outstanding. The number of shares has decreased by -0.53% in one year.
| Current Share Class | 98.15M |
| Shares Outstanding | 98.15M |
| Shares Change (YoY) | -0.53% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 96.86% |
| Float | 97.76M |
Valuation Ratios
The trailing PE ratio is 38.28 and the forward PE ratio is 25.09.
| PE Ratio | 38.28 |
| Forward PE | 25.09 |
| PS Ratio | 4.60 |
| Forward PS | 4.25 |
| PB Ratio | 3.73 |
| P/TBV Ratio | 25.07 |
| P/FCF Ratio | 27.25 |
| P/OCF Ratio | 20.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.98, with an EV/FCF ratio of 29.06.
| EV / Earnings | 40.57 |
| EV / Sales | 4.90 |
| EV / EBITDA | 17.98 |
| EV / EBIT | 26.27 |
| EV / FCF | 29.06 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.37 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.27 |
| Debt / FCF | 2.14 |
| Interest Coverage | 15.90 |
Financial Efficiency
Return on equity (ROE) is 10.13% and return on invested capital (ROIC) is 7.34%.
| Return on Equity (ROE) | 10.13% |
| Return on Assets (ROA) | 6.43% |
| Return on Invested Capital (ROIC) | 7.34% |
| Return on Capital Employed (ROCE) | 11.16% |
| Revenue Per Employee | $320,595 |
| Profits Per Employee | $38,705 |
| Employee Count | 17,787 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 4.70 |
Taxes
In the past 12 months, STERIS has paid $220.35 million in taxes.
| Income Tax | 220.35M |
| Effective Tax Rate | 24.18% |
Stock Price Statistics
The stock price has increased by +23.47% in the last 52 weeks. The beta is 1.03, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +23.47% |
| 50-Day Moving Average | 247.95 |
| 200-Day Moving Average | 236.57 |
| Relative Strength Index (RSI) | 67.30 |
| Average Volume (20 Days) | 788,760 |
Short Selling Information
The latest short interest is 958,740, so 0.98% of the outstanding shares have been sold short.
| Short Interest | 958,740 |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 0.98% |
| Short % of Float | 0.98% |
| Short Ratio (days to cover) | 1.63 |
Income Statement
In the last 12 months, STERIS had revenue of $5.70 billion and earned $688.44 million in profits. Earnings per share was $6.97.
| Revenue | 5.70B |
| Gross Profit | 2.54B |
| Operating Income | 1.06B |
| Pretax Income | 911.11M |
| Net Income | 688.44M |
| EBITDA | 1.55B |
| EBIT | 1.06B |
| Earnings Per Share (EPS) | $6.97 |
Balance Sheet
The company has $319.20 million in cash and $2.06 billion in debt, giving a net cash position of -$1.74 billion or -$17.72 per share.
| Cash & Cash Equivalents | 319.20M |
| Total Debt | 2.06B |
| Net Cash | -1.74B |
| Net Cash Per Share | -$17.72 |
| Equity (Book Value) | 7.02B |
| Book Value Per Share | 71.45 |
| Working Capital | 1.22B |
Cash Flow
In the last 12 months, operating cash flow was $1.30 billion and capital expenditures -$340.19 million, giving a free cash flow of $961.20 million.
| Operating Cash Flow | 1.30B |
| Capital Expenditures | -340.19M |
| Free Cash Flow | 961.20M |
| FCF Per Share | $9.79 |
Margins
Gross margin is 44.51%, with operating and profit margins of 18.64% and 12.07%.
| Gross Margin | 44.51% |
| Operating Margin | 18.64% |
| Pretax Margin | 15.98% |
| Profit Margin | 12.07% |
| EBITDA Margin | 27.24% |
| EBIT Margin | 18.64% |
| FCF Margin | 16.86% |
Dividends & Yields
This stock pays an annual dividend of $2.52, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | $2.52 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | 10.09% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 34.42% |
| Buyback Yield | 0.53% |
| Shareholder Yield | 1.48% |
| Earnings Yield | 2.63% |
| FCF Yield | 3.67% |
Analyst Forecast
The average price target for STERIS is $268.25, which is 0.52% higher than the current price. The consensus rating is "Buy".
| Price Target | $268.25 |
| Price Target Difference | 0.52% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 6.79% |
| EPS Growth Forecast (5Y) | 16.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.37 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.37 |
| Piotroski F-Score | 7 |